The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder

Journal of the Pakistan Medical Association

Volumn 58, Issue 9, 2008, Pages 479-481

  Basiri, Abbas ^a   Ozhand, Ardalan ^a   Karami, Hormoz ^a   Parham, Halimi Asl ^a   Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CYSTECTOMY; EUROPE; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE CARCINOMA; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 50949106637     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000 .The global picture . Eur J Cancer 2001, 37 Suppl 8:S4-66.
2. Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Beltran AL, Bostwick DG Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol. 2005;36:646-54.
3. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993, 71(3 Suppl):933-38.
4. Cancer incidence in five continents Volume VIII. IARC Sci Publ.2002; 155:1-781.
5. Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am J Epidemiol. 2007;166:71-78 Epub 2007.
6. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S; JPHC Study Group. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008; 167:71-77.
7. Safarinejad MR. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran. Ann Oncol. 2006;17:1166-71. Epub 2006.
8. Schoenberg M. Management of invasive and metastasis bladder cancer. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr, editors. Campbell's Urology.8th Ed .Philadelphia: WB Saunders. 2002 pp 2803-17.
9. Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MK et al. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol. 2007;33:167-73.
10. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murply GP, et al. AJCC cancer staging manual/American Joint Committee on Cancer. Fifth edition. Philadelphia, Lippincott - Raven. 1997.
11. Gleason DF, Mellinger GT Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging 1974. J Urol 2002,167:953-58
12. Glover FE Jr, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T. et al. The epidemiology of prostate cancer in Jamaica. J Urol 1998, 159:1984-86.
13. Li X, Tsuji I, Kuwahara M, Zhang H, Wang H, Zhang L. et al. Mass screening of prostate cancer in Changchun City of China. Int Urol Nephrol. 2004;36:541-48.
14. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995, 55:1937-40.
15. Karr DJP. Prostate cancer in the United States and Japan. Adv Exp Med Biol 1992, 324:17-28
16. Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR. Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int. 2005;75:213-16.
17. Konety BR, Bird VY, Deorah S, Dahmoush L. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 2005;174:1785-88.
18. Liedberg F, Chebil G, Davidsson T, Malmström PU, Sherif A, Månsson W. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens. Aktuelle Urol 2003;34:333-36.
19. Soos G, Tsakiris I, Szanto J, Turzo C, Haas PG, Dezso B. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol. 2005;48:739-44.
20. Plante P, Lesourd A, Blanchet P, Castagnola C, Coloby P, Daffer N. et al. Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens. Prog Urol 1998, 8:47-50.
21. Abbas F, Hochberg D, Civantos F, Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 1996, 30:322-26.